NCT07551596 2026-05-15Testing the Combination of Anti-Cancer Drugs, Botensilimab (AGEN1181) and Balstilimab (AGEN2034), After Standard Treatment for Colorectal Cancer, Combat TrialNational Cancer Institute (NCI)Phase 2 Not yet recruiting20 enrolled